These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 26136970)
1. Platelet-derived miR-92a downregulates cysteine protease inhibitor cystatin C in type II diabetic lower limb ischemia. Zhang Y; Guan Q; Jin X Exp Ther Med; 2015 Jun; 9(6):2257-2262. PubMed ID: 26136970 [TBL] [Abstract][Full Text] [Related]
2. Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? Liu F; Shen J; Zhao J; Zeng H; Li L; Zhao J; Lu F; Bao Y; Jia W PLoS One; 2013; 8(7):e66907. PubMed ID: 23843968 [TBL] [Abstract][Full Text] [Related]
3. Lipolysis by downregulating miR-92a activates the Wnt/β-catenin signaling pathway in hypoxic rats. Cheng J; Song Q; Yang Y; Sun Z; Tian X; Tian X; Feng L Biomed Rep; 2020 Oct; 13(4):33. PubMed ID: 32793347 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease. Wang W; Li Z; Zheng Y; Yan M; Cui Y; Jiang J Lipids Health Dis; 2019 Jan; 18(1):22. PubMed ID: 30670045 [TBL] [Abstract][Full Text] [Related]
5. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Hu S; Liu L; Chang EB; Wang JY; Raufman JP Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716 [TBL] [Abstract][Full Text] [Related]
6. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance. Gong J; He L; Ma J; Zhang J; Wang L; Wang J J BUON; 2017; 22(2):454-461. PubMed ID: 28534369 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4. Liu H; Li G; Zhao W; Hu Y Med Sci Monit; 2016 Jul; 22():2451-62. PubMed ID: 27411964 [TBL] [Abstract][Full Text] [Related]
8. The effects and mechanism of miR-92a and miR-126 on myocardial apoptosis in mouse ischemia-reperfusion model. Jiang C; Ji N; Luo G; Ni S; Zong J; Chen Z; Bao D; Gong X; Fu T Cell Biochem Biophys; 2014 Dec; 70(3):1901-6. PubMed ID: 25064220 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a serves as a risk factor in sepsis-induced ARDS and regulates apoptosis and cell migration in lipopolysaccharide-induced HPMEC and A549 cell injury. Xu F; Yuan J; Tian S; Chen Y; Zhou F Life Sci; 2020 Sep; 256():117957. PubMed ID: 32534035 [TBL] [Abstract][Full Text] [Related]
10. Role of miR Liu Y; Hu Q; Ao J; Li H; Li M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):280-289. PubMed ID: 32386020 [TBL] [Abstract][Full Text] [Related]
11. MiR-92a promotes the invasion and migration of colorectal cancer by targeting RECK. Wei QD; Zheng WB; Sun K; Xue Q; Yang CZ; Li GX Int J Clin Exp Pathol; 2019; 12(5):1565-1577. PubMed ID: 31933974 [TBL] [Abstract][Full Text] [Related]
12. Regulation of miR-92a on vascular endothelial aging via mediating Nrf2-KEAP1-ARE signal pathway. Liu H; Wu HY; Wang WY; Zhao ZL; Liu XY; Wang LY Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2734-2742. PubMed ID: 28678311 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92a-3p Regulates Aggrecanase-1 and Aggrecanase-2 Expression in Chondrogenesis and IL-1β-Induced Catabolism in Human Articular Chondrocytes. Mao G; Wu P; Zhang Z; Zhang Z; Liao W; Li Y; Kang Y Cell Physiol Biochem; 2017; 44(1):38-52. PubMed ID: 29241192 [TBL] [Abstract][Full Text] [Related]
14. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease]. Wang H; Lu HM; Yang WH; Luo C; Lu SH; Zhou Y; Lin YZ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):215-8. PubMed ID: 22464573 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3. Luo S; Li N; Yu S; Chen L; Liu C; Rong J Exp Ther Med; 2017 Aug; 14(2):1227-1234. PubMed ID: 28810582 [TBL] [Abstract][Full Text] [Related]
16. MiR-92a contributes to the cardiovascular disease development in diabetes mellitus through NF-κB and downstream inflammatory pathways. Wang WY; Zheng YS; Li ZG; Cui YM; Jiang JC Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3070-3079. PubMed ID: 31002156 [TBL] [Abstract][Full Text] [Related]
17. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer. Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956 [TBL] [Abstract][Full Text] [Related]
18. Aspirin resistance may be identified by miR-92a in plasma combined with platelet distribution width. Binderup HG; Houlind K; Madsen JS; Brasen CL Clin Biochem; 2016 Oct; 49(15):1167-1172. PubMed ID: 27208561 [TBL] [Abstract][Full Text] [Related]
19. Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes. Samak M; Kaltenborn D; Kues A; Le Noble F; Hinkel R; Germena G Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052738 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of microRNA-92a ameliorates lipopolysaccharide-induced endothelial barrier dysfunction by targeting ITGA5 through the PI3K/Akt signaling pathway in human pulmonary microvascular endothelial cells. Xu F; Zhou F Int Immunopharmacol; 2020 Jan; 78():106060. PubMed ID: 31841757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]